Novavax coronavirus vaccine becomes fifth to begin Phase 3 trials in United States
Novavax on Monday announced the start of the Phase 3 trial of its Covid-19 vaccine in the United States and Mexico. It is the fifth company to launch a large-scale trial of a coronavirus vaccine in the United States. The trial for the vaccine candidate, known as NVX-CoV2373, will evaluate safety, efficacy and immune response
Continue Reading